Literature DB >> 10381354

Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts.

S Ogawa1, T Urano, T Hosoi, M Miyao, S Hoshino, M Fujita, M Shiraki, H Orimo, Y Ouchi, S Inoue.   

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) protein as well as its transcript was detected in primary osteoblasts derived from rat calvariae. To analyze the possible involvement of PPARgamma in the human bone metabolism, association between bone mineral density (BMD) and a polymorphism of PPARgamma gene was investigated in Japanese postmenopausal women. We examined a polymorphism corresponding to a silent C --> T transition located in exon 6 of the PPARgamma gene, that was previously reported to be associated with plasma leptin levels in the obese. The frequencies of the C and T alleles in the population studied here were 0.851 and 0.149, respectively. When we separated the subjects into two groups, one bearing at least one T allele (CT + TT) and the other which did not (CC), the former subjects had lower BMD (Z score of total body; 0.056 +/- 1.00. L2-4; -0.25 +/- 1.26, mean +/- standard deviation). These data suggest that there is an association between the restriction fragment length polymorphism (RFLP) of PPARgamma gene and BMD and the possible involvement of this single nucleotide polymorphism (SNP) in the cause of postmenopausal osteoporosis in Japanese women. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381354     DOI: 10.1006/bbrc.1999.0896

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  A strategy for identifying osteoporosis risk genes.

Authors:  David Rowe; Alexander Lichtler
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 3.  Genetic aspects of osteoporosis.

Authors:  Takayuki Hosoi
Journal:  J Bone Miner Metab       Date:  2010-08-10       Impact factor: 2.626

4.  Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee.

Authors:  S Cheng; H Afif; J Martel-Pelletier; M Benderdour; J-P Pelletier; G Hilal; P Haraoui; J-P Raynauld; D Choquette; H Fahmi
Journal:  Ann Rheum Dis       Date:  2006-10       Impact factor: 19.103

Review 5.  Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.

Authors:  Hiroshi Kawaguchi; Toru Akune; Masayuki Yamaguchi; Shinsuke Ohba; Naoshi Ogata; Ung-il Chung; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss.

Authors:  Frances J Drummond; John J Mackrill; Kathleen O'sullivan; Mary Daly; Fergus Shanahan; Michael G Molloy
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families.

Authors:  H Yue; J-W He; H Zhang; W-W Hu; Y-Q Hu; M Li; Y-J Liu; S-H Wu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2009-07-31       Impact factor: 4.507

8.  The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate.

Authors:  J Christopher Fritton; Yuki Kawashima; Wilson Mejia; Hayden-Williams Courtland; Sebastien Elis; Hui Sun; Yinjgie Wu; Clifford J Rosen; David Clemmons; Shoshana Yakar
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 9.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

10.  Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen.

Authors:  Terrie-Anne Cock; Jonathan Back; Florent Elefteriou; Gérard Karsenty; Philippe Kastner; Susan Chan; Johan Auwerx
Journal:  EMBO Rep       Date:  2004-09-10       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.